Stavanger, Norway

Inge B Henrikson


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inge B. Henrikson: Innovating Submicron Technologies in Norway

Introduction

Inge B. Henrikson is an esteemed inventor based in Stavanger, Norway. With a profound understanding of particle technology, he holds a patent that is poised to impact the pharmaceutical industry significantly. His work primarily focuses on processes that enable the generation of submicron particles of water-insoluble compounds, particularly drugs, enhancing their efficacy and usability.

Latest Patents

Inge's noteworthy patent encompasses a unique process for preparing submicron particles of water-insoluble compounds. This innovative technique involves stabilizing microparticulate suspensions with surface modifier molecules by rapidly expanding them into an aqueous medium from a compressed solution mixture. The process optionally includes homogenizing the resulting aqueous suspension using a high-pressure homogenizer, ensuring optimal particle size distribution and stability.

Career Highlights

Currently, Inge B. Henrikson is employed at Rtp Pharma, Inc., where he leverages his expertise in technology and innovation to drive advancements in drug formulation and delivery. His dedication to research and development has positioned him among the leading professionals in the field of pharmaceutical sciences.

Collaborations

Inge has collaborated with prominent colleagues such as Gary William Pace and Michael G. Vachon. Together, they contribute to pioneering research that seeks to overcome challenges in drug solubility and stability, pushing the boundaries of what's possible in pharmaceutical applications.

Conclusion

Inge B. Henrikson embodies the spirit of innovation within the pharmaceutical industry. His contributions through patented technology not only reflect his expertise as an inventor but also pave the way for future advancements in drug formulation. As he continues his work at Rtp Pharma, Inc., the potential for improved therapeutic compounds remains promising, contributing to better healthcare solutions worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…